Welcome to our dedicated page for Blue Bird SEC filings (Ticker: BLBD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Blue Bird's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Blue Bird's regulatory disclosures and financial reporting.
American Century Investment Management, American Century Companies and Stowers Institute report beneficial ownership of 2,267,131 shares of Blue Bird Corporation common stock, equal to 7.2% of the class. The cover pages show sole voting power for 2,206,388 shares and sole dispositive power for 2,267,131 shares, identifying the reporting persons and their joint disclosure of the position.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. It also notes that various clients advised by the investment adviser have rights to dividends or sale proceeds and that no single client advised by ACIM owns more than 5% of the class.
Blue Bird Corporation (BLBD) is the subject of a Form 144 notice reporting a proposed sale of 84,684 shares of common stock to be executed through Muriel Siebert & Co., Inc. on 08/13/2025 on NASDAQ, with an aggregate market value listed as $4,783,800.00. The filing shows these shares were acquired on 08/13/2025 via a stock option exercise, with cash used to pay the exercise price.
The form also lists recent sales during the past three months by the person for whose account the securities are to be sold (named as Phil Horlock), including sales on 06/10/2025 (8,860 shares, $363,614.00), 06/11/2025 (13,289 shares, $554,106.93), 06/12/2025 (14,875 shares, $615,527.50), and 08/08/2025 (30,000 shares, $1,800,000.00). The filing states the total number of shares outstanding as 31,703,044. The notice is a regulatory disclosure of a planned insider sale and does not itself provide commentary on company operations or forward guidance.
Blue Bird Corporation (BLBD) reported a Form 144 disclosing that 8,877 shares of common stock were sold through Muriel Siebert & Co. on 08/11/2025 for an aggregate market value of $490,187.94. The shares were acquired the same day by a stock option exercise and payment was made in cash to cover the exercise price. The filing states the transaction was executed through a broker and shows total shares outstanding of 31,699,259, making the sale about 0.028% of the outstanding common stock. The filer also certifies there is no undisclosed material information.
Phil Horlock, a director of Blue Bird Corporation (BLBD), reported a sale of company common stock on 08/08/2025. The Form 4 shows a transaction coded as a sale of 30,000 shares at a price shown as $60 per share, leaving the reporting person with 240,766 shares beneficially owned after the transaction. The Form 4 was signed by an attorney-in-fact, Matthew Meziere, on 08/11/2025.
Blue Bird Corp's Form 4 reports that Chief Financial Officer Radulescu Razvan sold 700 shares of common stock on 08/08/2025 at $60.02 per share. After the transaction he beneficially owns 47,503 shares, held directly. The filing lists no derivative transactions and was filed by a single reporting person.
Blue Bird Corporation (BLBD) submitted a Form 144 notice for the proposed sale of 30,000 common shares through UBS Financial Services with an aggregate market value of $1,800,000. The 30,000 shares represent approximately 0.095% of the 31,707,943 shares outstanding. The shares were acquired on 06/08/2016 by RSU vesting. The filing lists prior sales in June 2025 of 8,860 shares (06/10/2025, $363,614), 13,289 shares (06/11/2025, $554,106.93) and 14,875 shares (06/12/2025, $615,527.50), totaling 37,024 shares and $1,533,248.43 in gross proceeds over the past three months. The proposed sale date is approximately 08/08/2025 on NASDAQ. The filer affirms no undisclosed material information in the remarks.
What the filing says: The Form 144 shows a proposed sale of 1,000 common shares of Blue Bird Corporation (BLBD) through Muriel Siebert & Co., with an aggregate market value of $60,000. The shares were acquired by RSU vesting on 07/01/2025 and the proposed sale date is 08/08/2025.
Other disclosed activity: The filing also lists two prior sales by Razvan Radulescu of 10,000 shares each on 07/08/2025 and 08/07/2025 with gross proceeds shown. The notice includes the required signer representation that the seller is not aware of undisclosed material information about the issuer.
Blue Bird Corp. (BLBD) Form 4 filing discloses that Chief Financial Officer Razvan Radulescu sold 10,000 common shares on 08/07/2025 at a weighted-average price of $53.21 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on 08/12/2024, indicating it was pre-scheduled. Following the sale, the CFO directly holds 48,203 BLBD shares. No derivative securities were involved and no additional transactions were reported. The filing was signed by attorney-in-fact Matthew Meziere on 08/08/2025.